Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,235
Closed -$204K 2431
2020
Q3
$204K Sell
6,235
-172
-3% -$7.28K ﹤0.01% 2223
2020
Q2
$290K Buy
6,407
+1,755
+38% +$89.7K ﹤0.01% 2043
2020
Q1
$212K Buy
+4,652
New +$210K ﹤0.01% 2074
2019
Q3
Sell
-2,554
Closed -$120K 2340
2019
Q2
$120K Buy
+2,554
New +$108K ﹤0.01% 2332

Other funds holding ATEX

Aperio Group's ATEX Position: Q4 2020 in Review

Aperio Group sold out of Anterix (ATEX) in Q4 2020, closing a stake of 6,235 shares — an estimated $204K sold.

Aperio Group first reported a position in ATEX in Q2 2019 and held it in 4 quarters. The position peaked at $290K in Q2 2020. 88 funds tracked by Wall St. Rank hold ATEX as of Q4 2020.

  • Aperio Group reported no remaining Anterix position as of Q4 2020 after selling out during the quarter.
  • Aperio Group sold 6,235 Anterix shares in Q4 2020, an estimated $204K.
  • Aperio Group first reported a position in Anterix in Q2 2019 and held it in 4 quarters.
  • Aperio Group's Anterix position peaked at $290K in Q2 2020.
  • 88 funds tracked by Wall St. Rank held Anterix as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.